The jury is out on how the Reserve Bank of India (RBI) plans to solve this problem. Some analysts believe the RBI may dust off a toolkit unused since 2017 – of organising standalone large-scale open market sales of sovereign debt.
5 pharma stks with upside potential of up to 12%
Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to